Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02292082 · ClinicalTrials.gov registry record · Phase 4
The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)
A Phase 4 study of Osteoarthritis, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- Phase 4
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT02292082: Completed Phase 4 study of Osteoarthritis, sponsored by Hospital for Special Surgery, New York.
NCT02292082 is a Phase 4 study of Osteoarthritis that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 111 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02292082, a Phase 4 study of Osteoarthritis, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
Total knee replacement is associated with severe post-operative pain. The purpose of this study is to compare two methods of treatment for pain control following Total Knee Replacement with an accelerated physical therapy protocol to aid the achievement of rehab milestones.
Primary Outcome
Time to reach physical therapy (PT) goals
Conditions Studied
Interventions
- DRUG Bupivacaine
- DRUG Normal saline
- DRUG Methylprednisolone
- DRUG Cefazolin
- DRUG Morphine
Study Locations (1)
New York
- Hospital for Special Surgery - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-08 |
| Phase | Phase 4 |
What the finished NCT02292082 record still lists
NCT02292082 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 5 interventions - of which Bupivacaine is the first listed.
NCT02292082 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02292082 about?
NCT02292082 is a clinical study titled "The Combination of Adductor Canal Block and Periarticular Injection. A Novel Technique for Patients Undergoing Total Knee Replacement (ACB PAI)". Total knee replacement is associated with severe post-operative pain. The purpose of this study is to compare two methods of treatment for pain control following Total Knee Replacement with an accelerated physical therapy protocol to aid the achievement of rehab milestones.
What is the current status of trial NCT02292082?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 111 participants. The study started on 2014-11. Estimated completion is 2016-08.
What conditions does trial NCT02292082 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT02292082?
The interventions under investigation include: Bupivacaine (DRUG), Normal saline (DRUG), Methylprednisolone (DRUG), Cefazolin (DRUG), Morphine (DRUG).
Who is sponsoring clinical trial NCT02292082?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02292082 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02292082's enrollment target sits among peer trials
111 85th of 135 higher than 51 of 135 other Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department
RECRUITING · Phase 4
-
Preoperative Correction of Vitamin D Deficiency in Total Joint Arthroplasty (TJA)
ACTIVE NOT RECRUITING · Phase 4
-
Duloxetine in Osteoarthritis (OA) Pain
COMPLETED · Phase 4
-
TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis
COMPLETED · Phase 4
-
Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia